Crossmark

Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status

Crossref DOI link: https://doi.org/10.1007/s00415-018-9093-3

Published Online: 2018-10-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lunetta, Christian https://orcid.org/0000-0002-4788-1875
Lizio, Andrea

Tremolizzo, Lucio

Ruscica, Massimiliano

Macchi, Chiara

Riva, Nilo

Weydt, Patrick

Corradi, Ettore

Magni, Paolo

Sansone, Valeria
License Information

Text and Data Mining valid from 2018-10-22
More Information

Article History

Received: 25 June 2018

Revised: 9 October 2018

Accepted: 10 October 2018

First Online: 22 October 2018

Compliance with ethical standards

:

: The authors declare no financial support for the conduct of the study. Dr Lunetta served on a scientific advisory board for Neuraltus and Italfarmaco and has received funds from Agenzia Italiana per la Ricerca sulla SLA (ARISLA) and Ministry of Health (CCM2011). The other authors report no conflicts of interest.

: The study has been approved by our Ethics Committee. All data were gathered after informed consent was obtained from each participant, in accordance with specific national laws and the ethics standards laid down in the 1964 Declaration of Helsinki and its later amendments.